Be Prepared to Dispense Dovato, a New Combo Med for HIV

November 2019

Dovato (doh-VAH-toh) will be a new two-drug combo for HIV.

It combines 50 mg of dolutegravir (Tivicay) and 300 mg of lamivudine (Heptovir, etc) in a once-daily tab...and is a complete HIV regimen.

Dovato joins Juluca (dolutegravir/rilpivirine)...another two-med, one-pill complete regimen.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Med Histories Avoid Common Pitfalls With Med Lists
Med Safety Listen for Questions About the Safety of Ranitidine and Other Meds
Medication Errors Double-Check Microgram and Milligram Calculations
Hyperkalemia Think of Lokelma and Veltassa as Similar to Kayexalate for High Potassium
Alcohol Stay Alert for Patients Talking About Drinking Alcohol While on Meds
HIV & AIDS Be Prepared to Dispense Dovato, a New Combo Med for HIV
Dermatology Steer Patients Looking for Scar Treatments to the Pharmacist
Breast Cancer Reduce Errors With Breast Cancer Prevention Meds
Pain Management Watch for Med Changes to Treat Acute Pain for Patients on Buprenorphine/Naloxone
HIV & AIDS Don't Be Surprised to See Descovy Used to Prevent HIV
Diabetes & Endocrinology Get the Facts About Pancreas Inflammation Risk With Methimazole